Shepherd Kaplan Krochuk’s Galmed Pharmaceuticals GLMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-102
| Closed | -$167K | – | 246 |
|
|
2017
Q3 | $167K | Hold |
102
| – | – | 0.14% | 151 |
|
|
2017
Q2 | $114K | Buy |
+102
| New | +$114K | 0.07% | 183 |
|
|
2017
Q1 | – | Sell |
-159
| Closed | -$101K | – | 265 |
|
|
2016
Q4 | $101K | Sell |
159
-19
| -11% | -$12.1K | 0.03% | 220 |
|
|
2016
Q3 | $142K | Hold |
178
| – | – | 0.03% | 269 |
|
|
2016
Q2 | $144K | Hold |
178
| – | – | 0.04% | 263 |
|
|
2016
Q1 | $158K | Buy |
178
+74
| +71% | +$65.7K | 0.05% | 211 |
|
|
2015
Q4 | $142K | Sell |
104
-104
| -50% | -$142K | 0.04% | 300 |
|
|
2015
Q3 | $278K | Hold |
208
| – | – | 0.07% | 187 |
|
|
2015
Q2 | $376K | Hold |
208
| – | – | 0.07% | 197 |
|
|
2015
Q1 | $352K | Hold |
208
| – | – | 0.06% | 208 |
|
|
2014
Q4 | $217K | Hold |
208
| – | – | 0.03% | 311 |
|
|
2014
Q3 | $321K | Sell |
208
-80
| -28% | -$123K | 0.04% | 274 |
|
|
2014
Q2 | $504K | Buy |
288
+144
| +100% | +$252K | 0.05% | 210 |
|
|
2014
Q1 | $297K | Buy |
+144
| New | +$297K | 0.03% | 299 |
|